Editorial: Novel agents and combinations for treatment of malignant pleural mesothelioma in pre-clinical models

Front Pharmacol. 2022 Sep 6:13:1015959. doi: 10.3389/fphar.2022.1015959. eCollection 2022.

Authors

Sze-Kwan Lam¹, Steven Eugene Mutsaers²

Affiliations

¹ Division of Respiratory Medicine, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam, Hong Kong SAR, China.
² Institute for Respiratory Health, University of Western Australia, Nedlands, WA, Australia.

No abstract available

Keywords: animal models; malignant pleural mesothelioma; novel combinations; novel therapies; review.

Publication types

Editorial